tailieunhanh - Osteopontin splice variants are differential predictors of breast cancer treatment responses

Osteopontin is a marker for breast cancer progression, which in previous studies has also been associated with resistance to certain anti-cancer therapies. It is not known which splice variants may mediate treatment resistance. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN